Abrey LE - Search Results

1

Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.

Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, de Groot J, Chang S, Mellinghoff I, Young RJ, Alexander BM, Colen R, Taylor JW, Arrillaga-Romany I, Mehta A, Huang RY, Pope WB, Reardon D, Batchelor T, Prados M, Galanis E, Wen PY, Cloughesy TF. Ellingson BM, et al. Among authors: abrey le. Neuro Oncol. 2018 Aug 2;20(9):1240-1250. doi: 10.1093/neuonc/noy053. Neuro Oncol. 2018. PMID: 29660006 Free PMC article. Clinical Trial.

2

Long-term survival in primary CNS lymphoma.

Abrey LE, DeAngelis LM, Yahalom J. Abrey LE, et al. J Clin Oncol. 1998 Mar;16(3):859-63. doi: 10.1200/JCO.1998.16.3.859. J Clin Oncol. 1998. PMID: 9508166

3

Sarcoidosis of the cauda equina mimicking leptomeningeal malignancy.

Abrey LE, Rosenblum MK, DeAngelis LM. Abrey LE, et al. J Neurooncol. 1998 Sep;39(3):261-5. doi: 10.1023/a:1005958205591. J Neurooncol. 1998. PMID: 9821112 Review.

4

High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors.

Abrey LE, Rosenblum MK, Papadopoulos E, Childs BH, Finlay JL. Abrey LE, et al. J Neurooncol. 1999 Sep;44(2):147-53. doi: 10.1023/a:1006383400353. J Neurooncol. 1999. PMID: 10619498 Clinical Trial.

5

Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.

Antunes NL, Khakoo Y, Matthay KK, Seeger RC, Stram DO, Gerstner E, Abrey LE, Dalmau J. Antunes NL, et al. Among authors: abrey le. J Pediatr Hematol Oncol. 2000 Jul-Aug;22(4):315-20. doi: 10.1097/00043426-200007000-00007. J Pediatr Hematol Oncol. 2000. PMID: 10959901

6

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.

Abrey LE, Olson JD, Raizer JJ, Mack M, Rodavitch A, Boutros DY, Malkin MG. Abrey LE, et al. J Neurooncol. 2001 Jul;53(3):259-65. doi: 10.1023/a:1012226718323. J Neurooncol. 2001. PMID: 11718258 Clinical Trial.

7

A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.

Khan RB, Raizer JJ, Malkin MG, Bazylewicz KA, Abrey LE. Khan RB, et al. Among authors: abrey le. Neuro Oncol. 2002 Jan;4(1):39-43. doi: 10.1093/neuonc/4.1.39. Neuro Oncol. 2002. PMID: 11772431 Free PMC article. Clinical Trial.

8

Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?

Khan RB, Shi W, Thaler HT, DeAngelis LM, Abrey LE. Khan RB, et al. Among authors: abrey le. J Neurooncol. 2002 Jun;58(2):175-8. doi: 10.1023/a:1016077907952. J Neurooncol. 2002. PMID: 12164690

9

Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.

Mason WP, Gentili F, Macdonald DR, Hariharan S, Cruz CR, Abrey LE. Mason WP, et al. Among authors: abrey le. J Neurosurg. 2002 Aug;97(2):341-6. doi: 10.3171/jns.2002.97.2.0341. J Neurosurg. 2002. PMID: 12186462 Clinical Trial.

10

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.

Abrey LE, Moskowitz CH, Mason WP, Crump M, Stewart D, Forsyth P, Paleologos N, Correa DD, Anderson ND, Caron D, Zelenetz A, Nimer SD, DeAngelis LM. Abrey LE, et al. J Clin Oncol. 2003 Nov 15;21(22):4151-6. doi: 10.1200/JCO.2003.05.024. J Clin Oncol. 2003. PMID: 14615443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page